热门资讯> 正文
ASLAN Pharmaceuticals申请为股东出售6190万股普通股
2024-06-13 04:41
- ASLAN Pharmaceuticals (NASDAQ:ASLN) filed a prospectus related to the offer and resale of up to 61,904,761 ordinary shares.
- This prospectus is not an offer to sell.
- Filing
More on ASLAN Pharmaceuticals
- ASLAN Pharmaceuticals announces receipt of Nasdaq notice
- Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals
- Historical earnings data for ASLAN Pharmaceuticals
- Financial information for ASLAN Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。